Skip to main content
July 22, 2020
Robin Carhart-Harris, PhD, who will speak at the 2020 virtual Psych Congress Elevate conference, discusses the power of psychedelics.
July 01, 2020
Psych Congress Steering Committee member and psychiatrist Rakesh Jain, MD, MPH, discusses reflections he has had during the COVID-19 pandemic about his 33 years of treating major depressive disorder.
March 19, 2020
Michael Thase, MD, of the University of Pennsylvania, discusses the use of second-generation antipsychotics as an adjunctive therapy in depression.
February 19, 2020
Michael Thase, MD, provides details on the strategy of combining antidepressants when treating patients with depression.
December 19, 2019
W. Clay Jackson, MD, DipTh, of the University of Tennessee College of Medicine in Memphis, discusses treatment approaches for patients with depression and substance use disorders.
December 05, 2019
W. Clay Jackson, MD, DipTh, explains the difference between major depressive disorder and major depressive disorder with mixed features.
November 07, 2019
Sanjay J. Mathew, MD, speaks about best practices for administering esketamine during his Psych Congress 2019 presentation "Top 5 Issues Clinicians Should Know about Ketamine Therapy."
February 18, 2019
In this video, Marlene Freeman, MD, discusses tools for detecting postpartum depression, how postpartum depression differs from other mental health disorders, and risk factors for postpartum depression.
February 11, 2019
In this video, Mark Zimmerman, MD, discusses severe depression and how it differs from mild and moderate depression, and the signs and treatment of severe depression.
February 07, 2019
Psychedelics researcher Robin Carhart-Harris, PhD, who delivered the opening session at Psych Congress 2018, spoke about the compounds at the World Economic Forum Annual Meeting in Davos, Switzerland.
Back to Top